USPH Accumulated Depreciation vs Net Tangible Assets Analysis

USPH Stock  USD 105.45  0.49  0.47%   
US Physicalrapy financial indicator trend analysis is much more than just breaking down US Physicalrapy prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether US Physicalrapy is a good investment. Please check the relationship between US Physicalrapy Accumulated Depreciation and its Net Tangible Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

Accumulated Depreciation vs Net Tangible Assets

Accumulated Depreciation vs Net Tangible Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of US Physicalrapy Accumulated Depreciation account and Net Tangible Assets. At this time, the significance of the direction appears to have strong relationship.
The correlation between US Physicalrapy's Accumulated Depreciation and Net Tangible Assets is 0.67. Overlapping area represents the amount of variation of Accumulated Depreciation that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of US Physicalrapy, assuming nothing else is changed. The correlation between historical values of US Physicalrapy's Accumulated Depreciation and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accumulated Depreciation of US Physicalrapy are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Accumulated Depreciation i.e., US Physicalrapy's Accumulated Depreciation and Net Tangible Assets go up and down completely randomly.

Correlation Coefficient

0.67
Relationship DirectionPositive 
Relationship StrengthSignificant

Accumulated Depreciation

Accumulated depreciation is the total amount of depreciation for US Physicalrapy fixed asset that has been charged to US Physicalrapy expense since that asset was acquired and made available for US Physicalrapy use. The accumulated depreciation account is US Physicalrapy asset account with a credit balance. It is also known as a contra asset account and appears on the balance sheet as a reduction from the gross amount of fixed assets reported by US Physicalrapy.

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.
Most indicators from US Physicalrapy's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into US Physicalrapy current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.As of now, US Physicalrapy's Enterprise Value Over EBITDA is increasing as compared to previous years. The US Physicalrapy's current Enterprise Value Multiple is estimated to increase to 17.58, while Selling General Administrative is projected to decrease to under 26.7 M.
 2021 2022 2023 2024 (projected)
Gross Profit117.2M112.0M112.0M117.6M
Total Revenue495.0M553.1M604.8M635.0M

US Physicalrapy fundamental ratios Correlations

0.890.960.980.930.760.90.770.821.00.820.950.70.690.80.980.950.920.95-0.410.960.930.99-0.40.540.55
0.890.950.90.830.570.890.560.710.890.710.880.730.470.710.820.780.810.76-0.240.750.830.85-0.480.60.61
0.960.950.930.960.750.890.70.740.970.740.90.670.580.690.940.920.840.91-0.390.890.960.93-0.380.510.52
0.980.90.930.870.630.890.670.890.960.890.930.750.70.880.930.910.970.89-0.260.910.880.95-0.460.60.61
0.930.830.960.870.850.840.770.680.950.680.840.580.60.590.950.940.780.95-0.490.920.990.91-0.290.420.43
0.760.570.750.630.850.740.920.320.810.320.730.470.60.280.840.780.480.89-0.840.850.820.81-0.260.350.36
0.90.890.890.890.840.740.750.580.910.580.970.880.690.640.860.780.750.82-0.440.820.80.89-0.70.790.8
0.770.560.70.670.770.920.750.40.80.40.770.550.650.40.840.730.560.87-0.850.860.730.82-0.380.460.46
0.820.710.740.890.680.320.580.40.761.00.680.490.580.950.770.810.970.710.040.760.720.76-0.20.340.35
1.00.890.970.960.950.810.910.80.760.760.950.70.680.750.980.940.880.96-0.480.960.940.99-0.40.540.55
0.820.710.740.890.680.320.580.41.00.760.680.490.580.950.770.810.970.710.040.760.720.76-0.20.340.35
0.950.880.90.930.840.730.970.770.680.950.680.860.730.740.90.830.840.87-0.40.870.820.94-0.640.740.75
0.70.730.670.750.580.470.880.550.490.70.490.860.690.590.630.550.650.58-0.20.590.530.67-0.90.980.98
0.690.470.580.70.60.60.690.650.580.680.580.730.690.610.720.740.690.72-0.30.750.610.71-0.590.630.64
0.80.710.690.880.590.280.640.40.950.750.950.740.590.610.730.720.950.650.040.720.630.77-0.320.450.46
0.980.820.940.930.950.840.860.840.770.980.770.90.630.720.730.970.870.99-0.530.990.960.98-0.330.470.48
0.950.780.920.910.940.780.780.730.810.940.810.830.550.740.720.970.880.96-0.390.960.970.93-0.240.380.39
0.920.810.840.970.780.480.750.560.970.880.970.840.650.690.950.870.880.82-0.10.860.810.88-0.360.50.51
0.950.760.910.890.950.890.820.870.710.960.710.870.580.720.650.990.960.82-0.60.990.950.96-0.290.420.43
-0.41-0.24-0.39-0.26-0.49-0.84-0.44-0.850.04-0.480.04-0.4-0.2-0.30.04-0.53-0.39-0.1-0.6-0.56-0.45-0.510.11-0.14-0.14
0.960.750.890.910.920.850.820.860.760.960.760.870.590.750.720.990.960.860.99-0.560.930.97-0.30.430.44
0.930.830.960.880.990.820.80.730.720.940.720.820.530.610.630.960.970.810.95-0.450.930.91-0.230.370.38
0.990.850.930.950.910.810.890.820.760.990.760.940.670.710.770.980.930.880.96-0.510.970.91-0.360.50.51
-0.4-0.48-0.38-0.46-0.29-0.26-0.7-0.38-0.2-0.4-0.2-0.64-0.9-0.59-0.32-0.33-0.24-0.36-0.290.11-0.3-0.23-0.36-0.97-0.97
0.540.60.510.60.420.350.790.460.340.540.340.740.980.630.450.470.380.50.42-0.140.430.370.5-0.971.0
0.550.610.520.610.430.360.80.460.350.550.350.750.980.640.460.480.390.510.43-0.140.440.380.51-0.971.0
Click cells to compare fundamentals

US Physicalrapy Account Relationship Matchups

US Physicalrapy fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets560.8M594.4M749.4M858.2M1.0B1.1B
Other Current Liab30.9M59.7M45.7M37.4M55.3M58.1M
Total Current Liabilities60.6M93.5M83.5M85.5M102.2M107.3M
Total Stockholder Equity240.3M276.2M295.6M315.8M476.2M500.0M
Property Plant And Equipment Net103.7M103.3M119.4M127.8M129.5M136.0M
Net Debt114.3M78.1M194.5M263.7M105.8M111.1M
Retained Earnings184.4M212.0M223.6M232.9M223.8M235.0M
Accounts Payable2.5M1.3M6.5M6.5M3.9M4.1M
Cash23.5M32.9M28.6M31.6M152.8M160.5M
Non Current Assets Total475.5M506.7M654.3M746.9M794.7M834.4M
Cash And Short Term Investments23.5M32.9M28.6M31.6M152.8M160.5M
Net Receivables56.1M50.9M62.4M68.6M71.8M75.4M
Common Stock Shares Outstanding12.8M12.8M12.9M13.0M14.2M12.9M
Liabilities And Stockholders Equity560.8M594.4M749.4M858.2M1.0B1.1B
Other Current Assets5.8M3.8M4.2M11.1M8.7M9.2M
Other Stockholder Equity55.8M64.0M71.9M78.7M249.5M261.9M
Total Liab181.4M184.4M297.0M373.6M375.8M394.6M
Property Plant And Equipment Gross103.7M103.3M97.9M208.0M214.4M225.1M
Total Current Assets85.4M87.6M95.2M111.3M233.4M245.0M
Short Long Term Debt Total137.8M111.0M223.1M295.3M258.6M271.5M
Non Currrent Assets Other1.5M1.5M(28.7M)(26.4M)158.0K165.9K
Non Current Liabilities Total120.8M90.9M213.5M288.1M273.7M287.3M
Short Term Debt27.2M32.4M31.3M41.6M42.9M45.1M
Intangible Assets52.6M56.3M86.4M108.8M109.7M115.2M
Good Will317.7M345.6M434.7M494.1M509.6M484.1M
Common Stock Total Equity148K149K150K151K173.7K144.3K
Common Stock149K150K151K152K172K147.0K
Other Assets1.5M14.1M1.6M1.6M1.9M2.1M
Long Term Debt50.4M16.6M117.6M175.8M139.0M145.9M
Property Plant Equipment22.1M21.7M119.4M127.8M146.9M154.3M
Other Liab10.2M12.3M21.7M34.3M39.5M41.5M
Net Tangible Assets7.7M6.6M(225.5M)(287.1M)(258.4M)(245.4M)
Noncontrolling Interest In Consolidated Entity930K1.4M1.5M1.6M1.4M1.3M
Retained Earnings Total Equity167.4M184.4M212.0M224.4M258.1M158.3M
Long Term Debt Total38.4M50.4M16.6M117.6M135.2M142.0M

Currently Active Assets on Macroaxis

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for USPH Stock analysis

When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Is US Physicalrapy's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.19)
Dividend Share
1.73
Earnings Share
1.13
Revenue Per Share
41.242
Quarterly Revenue Growth
0.048
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.